Back to search
Non-Immune Hydrops Fetalis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Immune Hydrops Fetalis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Immune Hydrops Fetalis trials you may qualify forEach year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common…
Brief Summary: Nonimmune hydrops fetalis (NIHF) is a potentially fatal condition characterized by abnormal fluid accumulation in two or more fetal compartments.…
Non-immune hydrops fetalis (NIHF) is diagnosed on prenatal ultrasound when abnormal fluid collections are seen in the fetus. NIHF carries significant risks of s…
The investigators aims to evaluate the safety of in utero hematopoietic stem cell transplantation in fetuses with alpha-thalassemia major performed at the time…
A fetal hydrops, also called a fetal anasarca, is the buildup of fluid in the serosa and / or fetal subcutaneous tissue. The diagnosis is made by ultrasound, po…